CTSB and brain aneurysm: Murine models show that treatment with E-64d, a non-selective cysteine protease inhibitor, provides neuroprotection after trauma, functioning primarily through inhibition of cathepsin B (48, 49) and administration of NC-2300, a selective cystine protease inhibitor, reduces the incidence of cerebral aneurysm (50).